Skip to content

Clinical trials

Recruiting Carcinoma, Non-Small-Cell Lung trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Recruiting Country / region: South Korea Clear all

93 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20172
20193
20204
20214
20226
20236
202422
202531
202615

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting93

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca11
Merck Sharp & Dohme LLC11
Eli Lilly and Company6
Bristol-Myers Squibb5
AbbVie3
Hoffmann-La Roche3
Janssen Research & Development, LLC3
Pfizer3
Samsung Medical Center3
Amgen2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung93
Lung Neoplasms25
Neoplasm Metastasis12
Neoplasms12
Squamous Cell Carcinoma of Head and Neck10
Pancreatic Neoplasms9
Breast Neoplasms8
Stomach Neoplasms8
Carcinoma7
Colorectal Neoplasms7

Trials

Showing 1 to 25 of 93. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.